Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Hutchmed
Hutchmed
Federation Francophone de Cancerologie Digestive
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
Eli Lilly and Company
Yale University
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute